Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and cell wall structures are fundamental components that define the boundary and maintain the viability of bacteria and fungi [1.1.1, 1.1.3]. The bacterial cell wall is primarily composed of peptidoglycan, a complex polymer that provides mechanical strength and prevents osmotic lysis; its synthesis is a major target for bactericidal antibiotics like beta-lactams and glycopeptides [1.1.1, 1.2.2]. The cell membrane is a lipid bilayer that serves as a selective permeability barrier and a scaffold for essential metabolic processes, such as ATP synthesis and nutrient transport [1.2.2, 1.4.1]. In fungi, the cell wall contains unique components like chitin and beta-glucans, while the membrane contains ergosterol instead of cholesterol, providing specific targets for antifungal agents like echinocandins and polyenes [1.2.4]. Drugs targeting these structures often exploit the biochemical differences between microbial and host cells to achieve selective toxicity [1.2.2, 1.2.5]. However, the clinical utility of these agents is frequently challenged by the evolution of resistance mechanisms, including the production of degradative enzymes like beta-lactamases and the modification of target structures [1.1.2, 1.3.4].
Inhibition of peptidoglycan synthesis and cross-linking (e.g., via PBPs or lipid II sequestration); disruption of cell membrane integrity and permeability; inhibition of fungal cell wall (beta-glucan) synthesis; binding to membrane sterols to form pores; inhibition of ergosterol biosynthesis.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and cell wall structures.